CAI - Caris Life Sciences • Financials

Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.

Complete and updated financials table with all primary indicators: Net Income, Revenue, EBITDA, Margin, ROE, Dividends

Year	Revenue	EBITDA	Net Inc	Net Mrg	EPS	Equity	ROE	Net Debt Aj	ND/EBITDA Aj	OCF Aj	Capex	FCF	Free Aj	Buyback	Dividend	Payout	DY
12/2022	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
12/2023	306	-271	-	L	L	-2,145	L	41	L	-291	-22	10	-314	0	0	-	-
12/2024	412	-208	-	L	L	-2,499	L	252	L	-264	-8	200	-272	0	0	-	-
12/2025	812	68	-	L	L	3,125	L	-421	-	13	-16	665	-3	-19	0	-	-

To see all financials—including updated, you must be Premium.